MedChemBio – collective research (Q11151): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed an Item: Change because item Q214249 was merged with Q4869) |
||
| Property / contained in NUTS | Property / contained in NUTS | ||
Revision as of 20:41, 27 December 2020
Project Q11151 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MedChemBio – collective research |
Project Q11151 in Czech Republic |
Statements
9,107,700.0 Czech koruna
0 references
13,011,000.0 Czech koruna
0 references
70 percent
0 references
19 January 2017
0 references
31 August 2019
0 references
MedChemBio
0 references
49°35'41.89"N, 17°16'31.12"E
0 references
77900
0 references
1.podprojekt pomůže ve fázi výroby hodnocených léčiv. přípravků pro moderní terapie(LPMT). Cílem je zajistit kvalitní výsledky pre-validačních a valid. studií, a vyvinout specif. metody kontroly kvality nových produktů pro dokončení vývoje a zahájení výroby LPMT v režimu SVP. Součástí bude i zahájení studie směřující k identifikaci biomarkerů účinnosti LPMT. a. (Czech)
0 references
1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_079/0008825
0 references